Inventor
HOCHMAN PAULA S
US15 patents
⚠️ This page may combine multiple inventors who share the name “HOCHMAN PAULA S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BIOGEN INC
4 patentsUS5925351AJul 20, 1999
Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease
BIOGEN INC78 citations97
US6669941B1Dec 30, 2003
Soluble lymphotoxin-β receptor as a therapeutic agent for treating TH-1 cell-associated autoimmune disease
BIOGEN INC42 citations96
US6403087B1Jun 11, 2002
Soluble lymphotoxin-β receptors as therapeutic agents for the treatment of immunological disease
BIOGEN INC52 citations96
US7255854B1Aug 14, 2007
Use of lymphotoxin-β receptor blocking agents for the treatment of antibody mediated immunological diseases
BIOGEN INC21 citations92
BIOGEN IDEC INC
4 patentsUS7309492B2Dec 18, 2007
Soluble lymphotoxin-β receptors as therapeutic agents for the treatment of systemic lupus erythematosus
BIOGEN IDEC INC13 citations92
US7427403B2Sep 23, 2008
Methods for inhibiting lymphotoxin β receptor signalling
BIOGEN IDEC INC9 citations84
US7951371B2May 31, 2011
Soluble lymphotoxin-β receptor fusion protein and methods for inhibiting lymphotoxin β-receptor signaling
BIOGEN IDEC INC2 citations62
US7744891B2Jun 29, 2010
Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases
BIOGEN IDEC INC3 citations62
BIOGEN MA INC
4 patentsBROWNING JEFFREY L
2 patentsUS8455445B2Jun 4, 2013
Methods for inhibiting lymphotoxin-β receptor signaling in TH1 cell-associated disorders
BROWNING JEFFREY L0 citations50
US8287874B2Oct 16, 2012
Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases
BROWNING JEFFREY L0 citations50